As a specialist in scientific information solutions, CAS is partnering with research organizations around the globe to tackle the rapidly evolving and complex challenge of COVID-19. Aligned with our mission as a division of the American Chemical Society, CAS is making a wide range of resources and expertise openly available to support this fight. If customized support from CAS scientists and technologists would be valuable to augment your COVID-19 research efforts, we welcome your outreach to the CAS Customer Center.
Joining Forces to Accelerate COVID-19 Treatments
Additional Resources
Blog
Exploring Knowledge Graphs for COVID-19 Drug Discovery
The methodology behind CAS knowledge graphs enhances potential drug identification for COVID-19 treatment and other diseases.
Blog
Coronavirus Variants: The Delta Variant and the Future Impact of Viral Mutations
If you are fully vaccinated, should you be worried about the impact of COVID-19 variants? Read this blog and learn about effectiveness of vaccines on …
Blog
Latest data on the safety and effectiveness of COVID-19 vaccines in children
On May 10, 2021, the U.S. FDA granted an extension of the emergency use authorization for Pfizer/BioNTech’s COVID-19 vaccine for children ages 12-15 …
Blog
Understanding the nanotechnology in COVID-19 vaccines
Lipid nanoparticles are a vital component of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting …
Blog
Do other vaccines protect you from COVID-19?
Quickly after the emergence of COVID-19, it became clear that vaccines and drugs would be needed to tackle the SARS-CoV-2 virus and bring an end to …
Blog
Top 5 COVID-19 vaccine questions answered
CAS addresses some of the most common scientific questions about the current COVID vaccine candidates.
Blog
Meet the mRNA vaccine rookies aiming to take down COVID-19
mRNA vaccines have many potential advantages over conventional vaccines in mitigating the spread and eventually ending the COVID-19 pandemic. Learn …
Blog
Building on “flu shot” success to tackle COVID-19
Pharmaceutical companies and public health officials are leveraging experience with the well-known influenza vaccine to support successful …
Blog
Seeking COVID-19 Therapeutic Candidates with a Computational Approach
Learn how machine learning procedures and CAS COVID-19 resources, including scientific insights, open access datasets and special reports are …
Blog
Taking aim at COVID-19’s most wanted targets
In support of ongoing research efforts to identify additional drugs for COVID-19, a team of CAS scientists analyzed published scientific information …
Blog
Storm warning – The critical role of cytokines in severe COVID-19
Serological tests indicate that inflammatory cytokine storm response is associated with COVID-19 severity and mortality. Understanding the biological …
Blog
Targeting ACE2 – Closing COVID-19’s cellular doorway
Since the outbreak of COVID-19, caused by SARS-CoV-2 virus, scientists have been racing to understand it. Extensive research has been devoted to …
Blog
The enemy within: How SARS-CoV-2 uses our own proteins to infect our cells
A critical step in the race to develop treatments for COVID-19 is to gain a clear understanding of how the virus enters our cells. This insight will …
Blog
Recent advances support scalability of COVID-19 diagnostic testing
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to grip the world. Large-scale testing is required for countries to successfully …
Blog
Joining Forces to Accelerate COVID-19 Treatments
With millions of confirmed COVID-19 cases, and many more likely going untested, researchers around the world are racing to find solutions to this …
Blog
Beating COVID-19: Insights and strategies for new vaccines and therapies
The outbreak of COVID-19, caused by the new virus SARS-CoV-2, has spread rapidly across the world. Since the first report from Wuhan, China on …
Infographics
Tracking COVID-19 Testing Technology - Infographic
This COVID-19 Testing Technology infographic summarizes both the key characteristics and benefits of the technologies needed, and the leading assay …